1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. STOKE THERAPEUTICS INC
Stoke Therapeutics Inc XNAS: STOK

Stoke Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

Read More
20.68 1.05 (5.35%)
New 52W High today
543.0K
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Stoke Therapeutics Inc is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
37.3 / 100
Momentum Score
Technically Bullish
77.1 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
24
1Yr Price target upside is 17%
9 analysts

23

S

7

W

5

O

1

T

SWOT Analysis

Stoke Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..